Peripheral neuropathy — all decisions

The appeal for service connection for a left-hand condition is dismissed as the Veteran was granted service connection for mononeuropathy to the left hand fourth finger with parasthesia of skin in an October 2025 rating decision.

The Board denied the Veteran's appeal for special monthly compensation based on loss of use of his left foot, as there was no evidence showing that the service-connected conditions resulted in functional limitation equal to that of amputation of the left foot with prosthesis.

The Board denied a compensable rating for erectile dysfunction and a higher rating for left upper extremity peripheral neuropathy with muscle weakness, but granted an earlier effective date for the 60 percent disability rating for thrombosis, TIA or cerebral infarction with impairment of sphincter control and voiding dysfunction, and for service connection for pharynx and/or larynx and/or swallowing conditions residuals.

The Board granted an increased rating of 20 percent for left ulnar neuropathy, finding that the Veteran's condition more nearly approximated moderate incomplete paralysis.

The Board granted a 60 percent disability rating for aphonia, restored the 60 percent rating for bladder dysfunction, and denied SMC based on loss of use of the right upper extremity.

The veteran withdrew her appeal for an initial rating in excess of 30 percent for myasthenia gravis with left lower extremity neuropathy.

The appeal is remanded to obtain additional evidence and ensure compliance with previous Board remand instructions.

The Board denied earlier effective dates for the awards of service connection and higher ratings for left and right upper extremity CTS with neuropathy.

The Board granted an effective date of April 8, 2022, for the award of service connection for cervical cancer and special monthly compensation (SMC) based on loss of use of a creative organ.

The Board denied service connection for bilateral hearing loss, left leg sciatic radiculopathy, right leg sciatic radiculopathy, and right upper extremity neuropathy due to a lack of evidence supporting current diagnoses or functional impairment.

The Board dismissed the appeals for service connection for a bilateral knee disability, bilateral upper and lower extremity peripheral neuropathy, lumbar spine disability, cervical spine disability, and chronic pain syndrome due to untimely notices of disagreement.

The Board granted service connection for left and right lower extremity peripheral neuropathy, finding that the conditions are related to in-service herbicide agent exposure.

The Board denied the veteran's claims for service connection for left and right upper extremity neuropathy, finding that there was no evidence of these conditions during service or within a reasonable time thereafter, and that they were not caused by toxic exposure or any other in-service event.

The Board granted a disability rating of 50 percent for the Veteran's left shoulder disability and service connection for peripheral neuropathy of the left upper extremity, both secondary to his service-connected left shoulder disability.

The Board denied the veteran's claims for increased ratings for type II diabetes mellitus, diabetic peripheral neuropathy of the right lower extremity, and diabetic peripheral neuropathy of the left lower extremity.

The Board denied the Veteran's claims for ratings in excess of 10 percent for left and right upper extremity ulnar neuropathy.

The Board granted service connection for left and right lower extremity peripheral neuropathy, finding that the conditions are related to Agent Orange exposure during the Veteran's service in Vietnam.

The Board granted service connection for diabetes mellitus, type II and neuropathy of the extremities due to in-service exposure to herbicide agents. The claims for a sinus disorder and facial skin disorder were remanded.

The Veteran's tinnitus is granted, while fibromyalgia, internal or external hemorrhoids, bilateral hearing loss, and neuropathy are denied.

The Veteran withdrew the appeals for entitlement to a rating in excess of 20 percent for diabetic peripheral neuropathy of both lower extremities.